The biomarker and causal roles of homoarginine in the development of cardiometabolic diseases: an observational and Mendelian randomization analysis

In this paper, researchers used Mendelian randomization to investigate High L-homoarginine (hArg) levels.

The results found that lifetime exposure to higher levels of circulating hArg does not seem to alter cardiometabolic disease risk.

Stay in the know

Our latest health headlines delivered to your inbox.